167 related articles for article (PubMed ID: 11081597)
1. Tumor growth and audiometric change in vestibular schwannomas managed conservatively.
Massick DD; Welling DB; Dodson EE; Scholfield M; Nagaraja HN; Schmalbrock P; Chakeres DW
Laryngoscope; 2000 Nov; 110(11):1843-9. PubMed ID: 11081597
[TBL] [Abstract][Full Text] [Related]
2. Conservative management of vestibular schwannomas - second review of a prospective longitudinal study.
Raut VV; Walsh RM; Bath AP; Bance ML; Guha A; Tator CH; Rutka JA
Clin Otolaryngol Allied Sci; 2004 Oct; 29(5):505-14. PubMed ID: 15373864
[TBL] [Abstract][Full Text] [Related]
3. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
Fisher LM; Doherty JK; Lev MH; Slattery WH
Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
[TBL] [Abstract][Full Text] [Related]
4. Are stage IV vestibular schwannomas preoperatively different from other stages?
Tringali S; Dubreuil C; Zaouche S; Ferber-Viart C
Otol Neurotol; 2008 Jan; 29(1):46-9. PubMed ID: 18046259
[TBL] [Abstract][Full Text] [Related]
5. A clinical, genetic and audiological study of patients and families with unilateral vestibular schwannomas. II. Audiological findings in 93 patients with unilateral vestibular schwannomas.
Neary WJ; Newton VE; Laoide-Kemp SN; Ramsden RT; Hillier VF; Kan SW
J Laryngol Otol; 1996 Dec; 110(12):1120-8. PubMed ID: 9015423
[TBL] [Abstract][Full Text] [Related]
6. Trends in the management of vestibular schwannomas at Johns Hopkins 1997-2007.
Tan M; Myrie OA; Lin FR; Niparko JK; Minor LB; Tamargo RJ; Francis HW
Laryngoscope; 2010 Jan; 120(1):144-9. PubMed ID: 19877188
[TBL] [Abstract][Full Text] [Related]
7. Consequences to hearing during the conservative management of vestibular schwannomas.
Walsh RM; Bath AP; Bance ML; Keller A; Rutka JA
Laryngoscope; 2000 Feb; 110(2 Pt 1):250-5. PubMed ID: 10680925
[TBL] [Abstract][Full Text] [Related]
8. Conservative treatment of vestibular schwannoma: a follow-up study on clinical and quality-of-life outcome.
Godefroy WP; Kaptein AA; Vogel JJ; van der Mey AG
Otol Neurotol; 2009 Oct; 30(7):968-74. PubMed ID: 19730147
[TBL] [Abstract][Full Text] [Related]
9. Conservative management of vestibular schwannomas: third review of a 10-year prospective study.
Hajioff D; Raut VV; Walsh RM; Bath AP; Bance ML; Guha A; Tator CH; Rutka JA
Clin Otolaryngol; 2008 Jun; 33(3):255-9. PubMed ID: 18559034
[TBL] [Abstract][Full Text] [Related]
10. Hearing in patients with intracanalicular vestibular schwannomas.
Caye-Thomasen P; Dethloff T; Hansen S; Stangerup SE; Thomsen J
Audiol Neurootol; 2007; 12(1):1-12. PubMed ID: 17033159
[TBL] [Abstract][Full Text] [Related]
11. The natural history of untreated vestibular schwannomas. Is there a role for conservative management?
Walsh RM; Bath AP; Bance ML; Keller A; Tator CH; Rutka JA
Rev Laryngol Otol Rhinol (Bord); 2000; 121(1):21-6. PubMed ID: 10865479
[TBL] [Abstract][Full Text] [Related]
12. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.
Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP
Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646
[TBL] [Abstract][Full Text] [Related]
13. Change in hearing during 'wait and scan' management of patients with vestibular schwannoma.
Stangerup SE; Caye-Thomasen P; Tos M; Thomsen J
J Laryngol Otol; 2008 Jul; 122(7):673-81. PubMed ID: 18088451
[TBL] [Abstract][Full Text] [Related]
14. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
15. Predictors of vestibular schwannoma growth and clinical implications.
Agrawal Y; Clark JH; Limb CJ; Niparko JK; Francis HW
Otol Neurotol; 2010 Jul; 31(5):807-12. PubMed ID: 20502379
[TBL] [Abstract][Full Text] [Related]
16. Conservative management of acoustic neurinomas: prospective study of long-term changes in tumor volume and auditory function.
Yamamoto M; Hagiwara S; Ide M; Jimbo M; Arai Y; Ono Y
Minim Invasive Neurosurg; 1998 Jun; 41(2):86-92. PubMed ID: 9651917
[TBL] [Abstract][Full Text] [Related]
17. Audiologic presentation of vestibular schwannomas in neurofibromatosis type 2.
Lalwani AK; Abaza MM; Makariou EV; Armstrong M
Am J Otol; 1998 May; 19(3):352-7. PubMed ID: 9596188
[TBL] [Abstract][Full Text] [Related]
18. Vestibular schwannoma: an understanding of growth should influence management decisions.
Solares CA; Panizza B
Otol Neurotol; 2008 Sep; 29(6):829-34. PubMed ID: 18636034
[TBL] [Abstract][Full Text] [Related]
19. Vestibular schwannoma volume as a predictor of hearing outcome after surgery.
Gjuric M; Mitrecic MZ; Greess H; Berg M
Otol Neurotol; 2007 Sep; 28(6):822-7. PubMed ID: 17554228
[TBL] [Abstract][Full Text] [Related]
20. Vestibular schwannoma growth: the continuing controversy.
Charabi S; Tos M; Thomsen J; Charabi B; Mantoni M
Laryngoscope; 2000 Oct; 110(10 Pt 1):1720-5. PubMed ID: 11037833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
